Alcohol septal ablation in the management of obstructive hypertrophic cardiomyopathy

Italian Heart Journal

Volumn 1, Issue 11, 2000, Pages 721-725

  Spirito, P ^a   Rubartelli, P ^a  

^a GALLIERA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

HEART ARRHYTHMIA; HEART VENTRICLE SEPTUM; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; REVIEW; RISK; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ETHANOL; HEART SEPTUM; HUMANS; NECROSIS; PATIENT SELECTION; PROGNOSIS; RISK FACTORS;

EID: 0033634714     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Hypertrophic cardiomyopathy: Interrelations of clinical manifestations, pathophysiology, and therapy
2. Hypertrophic cardiomyopathy. Clinical spectrum and treatment
3. The management of hypertrophic cardiomyopathy
4. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population
5. Operative treatment in hypertrophic subaortic stenosis: Techniques, and the results of pre and postoperative assessments in 83 patients
6. Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy
7. Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy
8. Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus
9. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and 3-month follow-up in 25 patients
10. Induction of subaortic septal ischaemia to reduce obstruction in hypertrophic obstructive cardiomyopathy. Studies to develop a new catheter-based concept of treatment
11. Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy
12. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy results with respect to intraprocedural myocardial contrast echocardiography
13. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy
14. Non-surgical septal reduction for hypertrophic obstructive cardiomyopathy outcome in the first series of patients
15. Intraprocedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: Detection of threatening myocardial necrosis distant from the septal target area
16. Perspectives on the role of new treatment strategies in hypertrophic obstructive cardiomyopathy
17. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy
18. Infective endocarditis in hypertrophic cardiomyopathy. Prevalence, incidence, and indications for antibiotic prophylaxis